Aurora Cannabis (ACB) early Tuesday disclosed its launch of inhalable resin cartridges for medical patients in the United Kingdom.
The company had previously launched its inhalable resin cartridges for patients in Canada and Australia, offering fast and controlled delivery of medical cannabis using indica and sativa cultivars, it said.
Shares of Aurora were down 1.2% in recent trading.
Price: 4.20, Change: -0.05, Percent Change: -1.22
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.